Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 5.8 Billion | USD 11.9 Billion | 8.2% | 2021 |
FrequentlyAsked Questions
Rise in occurrence of ailments such as heart disorders, neurological ailments, and cancer will boost radiopharmaceutical market trends.
According to Zion market research report, the global Radiopharmaceutical Market accrued earnings worth approximately 5.8(USD Billion) in 2021 and is predicted to gain revenue of about 11.9(USD Billion) by 2028, is set to record a CAGR of nearly 8.2% over the period from 2022 to 2028.
North America will contribute sizably towards the global market revenue over the projected timeline. A massive increase in Radiopharmaceutical Market size in sub-continent over 2022-2028 can be due to rise in occurrence of chronic disorders such as heart ailments and cancer in countries such as the U.S.
The key industry participants leveraging business space include Jubilant Pharmova, Lantheus Holdings Inc., Mallinckrodt Pharmaceuticals, Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications, The Bracco Group, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Bayer AG, IBA Molecular Imaging Private Limited, and Siemens Healthineers AG.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed